Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial

Dry AMD affects part of the eye’s retina that allows for clear central vision.

Macular Degeneration Treatment

Experimental drug shows promise for sight-stealing eye condition

Media Resources Clinical Center Home Page

Four decades of clinical trials: 14.2 million life-years gained, at $326 per year

Advances in Age-related Macular Degeneration Understanding and

Eye Health and Diet

Home - Tufts Graduate School of Biomedical Sciences - LibGuides at Tufts University

National Eye Institute National Eye Institute

CHILDREN'S DIAGNOSTIC & TREATMENT CENTER'S 16TH ANNUAL RIBBONS FOR THE CHILDREN RAISES $45,000 TO HELP CHILDREN AND FAMILIES - Florida Hospital News and Healthcare Report

Age-Related Macular Degeneration (AMD): Non-neovascular and

Age-Related Macular Degeneration (AMD)

NIH Science in Seconds - Week of March 18, 2024

A deeper look at pegcetacoplan

Nutrients, Free Full-Text